Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins
- PMID: 10565560
- DOI: 10.1034/j.1399-3038.1999.00030.x
Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins
Abstract
The ingestion of food antigens usually results in the induction of oral tolerance, but the clinical and immunologic consequences of brief exposure to cow's milk proteins during the neonatal period are not well-documented. The aim of this work was to study immunoglobulin (Ig)E and IgG responses to cow's milk proteins and ovalbumin after exposure during the first three days of life in infants who were otherwise exclusively breast-fed. A group of 129 infants was randomly assigned at birth to one of three feeding regimens: human milk (HM), cow's milk formula (CMF), or a casein hydrolysate formula (CHF), during the first three days of life. They were then all exclusively breast-fed for a varying period of time and followed for two years. Serum IgG and IgE antibodies to cow's milk proteins and ovalbumin (OVA) were analyzed in blood samples obtained at birth, at 4 days and at 2, 4, 8, 12 and 24 months of age. The levels of IgG antibodies to beta-lactoglobulin (IgG-BLG) and bovine serum albumin (IgG-BSA) were higher in the CMF and the HM groups than in the CHF group for up to two years. This was particularly obvious for IgG-BLG in infants who started weaning before two months. The levels of IgG antibodies to casein (IgG-CAS) were higher in the CMF group, as compared with the CHF group at 8 and 12 months. The levels of IgG antibodies to OVA were similar in all three feeding groups. The levels of IgE antibodies to CAS or OVA were similar in the three feeding groups. Exposure to cow's milk during the first three days of life stimulated IgG antibody production to cow's milk proteins and this was still obvious at 2 years of age, while feeding with a casein hydrolysate during the first three days of life was associated with low levels of IgG antibodies to cow's milk proteins.
Similar articles
-
IgG and IgA antibody levels to cow's milk are low at age 10 years in children born preterm.J Allergy Clin Immunol. 2002 Oct;110(4):658-63. doi: 10.1067/mai.2002.128077. J Allergy Clin Immunol. 2002. PMID: 12373277
-
Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula.J Allergy Clin Immunol. 1995 Dec;96(6 Pt 1):917-23. doi: 10.1016/s0091-6749(95)70229-6. J Allergy Clin Immunol. 1995. PMID: 8543750 Clinical Trial.
-
Ability of a new infant formula prepared from partially hydrolyzed bovine whey to induce anaphylactic sensitization: evaluation in a guinea pig model.Allergy. 1994 May;49(5):361-4. doi: 10.1111/j.1398-9995.1994.tb02282.x. Allergy. 1994. PMID: 8092434
-
Cow's Milk Allergy in Breastfed Infants: What We Need to Know About Mechanisms, Management, and Maternal Role.Nutrients. 2025 May 24;17(11):1787. doi: 10.3390/nu17111787. Nutrients. 2025. PMID: 40507056 Free PMC article. Review.
-
Prevention of Allergic Sensitization and Treatment of Cow's Milk Protein Allergy in Early Life: The Middle-East Step-Down Consensus.Nutrients. 2019 Jun 26;11(7):1444. doi: 10.3390/nu11071444. Nutrients. 2019. PMID: 31248015 Free PMC article.
Cited by
-
Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy.Eur J Nutr. 2010 Dec;49(8):501-4. doi: 10.1007/s00394-010-0109-8. Epub 2010 Apr 20. Eur J Nutr. 2010. PMID: 20405136 Clinical Trial.
-
Immune responses of female BALB/c and C57BL/6 neonatal mice to vaccination or intestinal infection are unaltered by exposure to breast milk lycopene.J Nutr. 2011 Jul;141(7):1326-30. doi: 10.3945/jn.110.136762. Epub 2011 May 18. J Nutr. 2011. PMID: 21593356 Free PMC article.
-
WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Cochrane Database Syst Rev. 2017 May 25;5(5):CD003664. doi: 10.1002/14651858.CD003664.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Oct 19;10:CD003664. doi: 10.1002/14651858.CD003664.pub6. PMID: 28542713 Free PMC article. Updated.
-
Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD003664. doi: 10.1002/14651858.CD003664.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2017 May 25;5:CD003664. doi: 10.1002/14651858.CD003664.pub5. PMID: 28293923 Free PMC article. Updated.
-
Infant formulas containing hydrolysed protein for prevention of allergic disease.Cochrane Database Syst Rev. 2018 Oct 19;10(10):CD003664. doi: 10.1002/14651858.CD003664.pub6. Cochrane Database Syst Rev. 2018. PMID: 30338526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources